Exciting Pipeline of news...9 Dec 2021 17:35
Looking back over the RNS form 29 November 2021...
"In PARALLEL [with CE-IVD certification], the product is being provided for review and evaluation to a range of potential commercial partners who have actively expressed interest in the product."
So commercial evaluation has been in progress for a week already :)
UK certification will follow CE-IVD certification, pending a sufficient number of patient samples - I don't see any problem with that at this time of year! :)
"The sensitivity and specificity of the assay on the entire cohort met the current requirements of the UK's MHRA Target Product Profile..."
- Very encouraging for UK approval :)